4.8 Article

Pharmaceutical Biotransformation is Influenced by Photosynthesis and Microbial Nitrogen Cycling in a Benthic Wetland Biomat

期刊

ENVIRONMENTAL SCIENCE & TECHNOLOGY
卷 56, 期 20, 页码 14462-14477

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.est.2c0356614462

关键词

trace organic; wetland; denitrification; biofilm; oxic-anoxic; algae

资金

  1. NSF ERC ReNUWIt (NSF) [G-62991-01]
  2. Colorado Higher Education Competitive Research Authority (CHECRA)
  3. National Institutes for Water Resources
  4. U.S. Department of Energy Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]
  5. U.S. DOE JGI
  6. Office of Science of the U.S. DOE
  7. U.S. Geological Survey (NIWR-USGS) subaward [DE-SC0019746]
  8. [NSF EEC-1028968]
  9. U.S. Department of Energy (DOE) [DE-SC0019746] Funding Source: U.S. Department of Energy (DOE)

向作者/读者索取更多资源

This study combines field-scale biomat and laboratory inhibition microcosms to investigate microbial processes contributing to pharmaceutical transformation in shallow open-water wetlands, revealing diverse activities including photosynthesis, nitrification, denitrification, and diatom dominance. The findings highlight the importance of different microbial clades and their environmental requirements for biotransformation.
In shallow, open-water engineered wetlands, design parameters select for a photosynthetic microbial biomat capable of robust pharmaceutical biotransformation, yet the contributions of specific microbial processes remain unclear. Here, we combined genome-resolved metatranscriptomics and oxygen profiling of a field-scale biomat to inform laboratory inhibition microcosms amended with a suite of pharmaceuticals. Our analyses revealed a dynamic surficial layer harboring oxic-anoxic cycling and simultaneous photosynthetic, nitrifying, and denitrifying microbial transcription spanning nine bacterial phyla, with unbinned eukaryotic scaffolds suggesting a dominance of diatoms. In the laboratory, photosynthesis, nitrification, and denitrification were broadly decoupled by incubating oxic and anoxic microcosms in the presence and absence of light and nitrogen cycling enzyme inhibitors. Through combining microcosm inhibition data with field-scale metagenomics, we inferred microbial clades responsible for biotransformation associated with membrane-bound nitrate reductase activity (emtricitabine, trimethoprim, and atenolol), nitrous oxide reduction (trimethoprim), ammonium oxidation (trimethoprim and emtricitabine), and photosynthesis (metoprolol). Monitoring of transformation products of atenolol and emtricitabine confirmed that inhibition was specific to biotransformation and highlighted the value of oscillating redox environments for the further transformation of atenolol acid. Our findings shed light on microbial processes contributing to pharmaceutical biotransformation in open-water wetlands with implications for similar nature-based treatment systems.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据